INTRODUCTION Renal transplantation provides a significant mortality benefit to patients
with End-Stage Kidney Disease (ESKD) compared to those remaining on renal replacement …

Introduction and objective: Onconephrology is a new and evolving field that deals with
kidney complications in patients with cancer as well as the management of cancer in …

Background: Erythropoiesis-stimulating agents (ESAs), intravenous iron, and blood
transfusion are used to treat anemia in both end-stage renal disease (ESRD) and cancer …

Interventions: He received concomitant single-agent oral etoposide (6 cycles) and local
radiotherapy. Etoposide 100 mg once daily combined with thoracic radiation treatment (2 …

Background. Renal anastomosing hemangioma (RAH) is a very rare distinct entity
composed of anastomosing sinusoidal (spleen-like) capillary-sized vessels lined by flat or …

We investigated the long-term outcomes of the Japanese hemodialysis patients with
prostate cancer detected by prostate-specific antigen (PSA) screening. Clinical data of 646 …

Purpose This study is to compare risks of developing renal cell carcinoma or urothelial
cancer between hemodialysis (HD) and peritoneal dialysis (PD) patients. Methods The age …

Introduction Management of breast cancer patients undergoing hemodialysis (HD) is difficult
because of a lack of evidence about drug selection, dose adjustment, and surgical …

For patients with end-stage renal disease (ESRD), peritoneal dialysis (PD) and
hemodialysis (HD) are important renal replacement treatments. Patients on dialysis usually …

Kidney cancer is one of the most common cancers globally, ranking 9th and 14th among
men and women, respectively. Advances in diagnostic techniques have enabled earlier and …